Glaucoma
Glaucoma is a group of eye conditions that damage the optic nerve, often due to high eye pressure, leading to vision loss if not treated. It can be asymptomatic in early stages, making regular eye exams crucial.
Dry Eye Disease: PRGF Eye Drops for Glaucoma Patients
We are studying whether PRGF eye drops can help relieve dry eye symptoms in patients with glaucoma. The trial also looks at the safety of these eye drops for this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Dry Eye Disease
Dry eye disease occurs when your tears aren't able to provide adequate lubrication for your eyes, leading to discomfort and potential damage to the eye's surface. It can be caused by various factors, including aging and environmental conditions.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a man or woman over 50 years old?
- Do you have glaucoma or ocular hypertension (high eye pressure) that requires treatment?
- Do you have moderate to severe dry eye syndrome (dry eyes) as defined by an OSDI score of 13 or higher?
- Are you currently pregnant or breastfeeding?
- Have you had any eye surgery in the last 3 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Plasma Rich In Growth Factors
Platelet Concentrate
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Donostia
Ophtalmology
Donostia / San Sebastián, Spain
Sponsor: Biotechnology Institute I Mas D S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.